Old Web
English
Sign In
Acemap
>
authorDetail
>
Julian O’Neil Moore
Julian O’Neil Moore
Dermatology
Medicine
moderate to severe
in patient
Atopic dermatitis
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
27550 Durability of response to abrocitinib in patients with moderate-to-severe atopic dermatitis (AD) after treatment discontinuation in a phase 2b trial
2021
Journal of The American Academy of Dermatology
Melinda Gooderham
Giampiero Girolomoni
Julian O’Neil Moore
Jonathan I. Silverberg
Robert Bissonnette
Seth Forman
Elena Peeva
Pinaki Biswas
Hernan Valdez
Gary Chan
Show All
Source
Cite
Save
Citations (0)
16466 Predictors of maintenance of response in patients with moderate to severe atopic dermatitis after oral Janus kinase 1 selective inhibitor abrocitinib interruption
2020
Journal of The American Academy of Dermatology
Melinda Gooderham
Giampiero Girolomoni
Julian O’Neil Moore
Jonathan I. Silverberg
Madelyn Curto
Weidong Zhang
Marco DiBonaventura
Hernan Valdez
Show All
Source
Cite
Save
Citations (0)
1